{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:14:45Z","timestamp":1792250085782,"version":"4.4.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.psc.2009.05.004","type":"journal-article","created":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T05:47:42Z","timestamp":1251524862000},"page":"549-575","source":"Crossref","is-referenced-by-count":394,"title":["The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology"],"prefix":"10.1016","volume":"32","author":[{"given":"Elizabeth I.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"Ressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2009.05.004_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biopsych.2005.05.019","article-title":"The neural correlates of anhedonia in major depressive disorder","volume":"58","author":"Keedwell","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","article-title":"Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders","volume":"11","author":"Drevets","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.psc.2009.05.004_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.neuro.24.1.167","article-title":"An integrative theory of prefrontal cortex function","volume":"24","author":"Miller","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.psc.2009.05.004_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(98)00184-5","article-title":"The cortical representation of pain","volume":"79","author":"Treede","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.psc.2009.05.004_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/cercor\/2.6.435-a","article-title":"Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions","volume":"2","author":"Vogt","year":"1992","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.psc.2009.05.004_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainresrev.2004.06.001","article-title":"Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?","volume":"47","author":"Gysling","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.psc.2009.05.004_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.npep.2004.12.008","article-title":"One for all or one for one: does co-transmission unify the concept of a brain galanin \u201csystem\u201d or clarify any consistent role in anxiety?","volume":"39","author":"Barrera","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psc.2009.05.004_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000126156","article-title":"Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus","volume":"55","author":"Honkaniemi","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psc.2009.05.004_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(00)00549-5","article-title":"Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons","volume":"405","author":"Palkovits","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.psc.2009.05.004_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/frne.1996.0008","article-title":"The impact of physiological stimuli on the expression of corticotropin-releasing hormone (CRH) and other neuropeptide genes","volume":"17","author":"Watts","year":"1996","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.psc.2009.05.004_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1523\/JNEUROSCI.22-03-00959.2002","article-title":"Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus","volume":"22","author":"Cole","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.psc.2009.05.004_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.psc.2009.05.004_bib13","unstructured":"Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. ed. 3. Washington (DC): The American Psychiatric Publishing; 2004. p. 717\u201365, 847\u201368, 913\u201335."},{"key":"10.1016\/j.psc.2009.05.004_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2007.05.009","article-title":"The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease","volume":"115","author":"Lang","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.psc.2009.05.004_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0165-6147(02)02074-6","article-title":"The participation of galanin in pain processing at the spinal level","volume":"23","author":"Liu","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.psc.2009.05.004_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/1357-2725(95)00008-D","article-title":"Galanin 10 years with a neuroendocrine peptide","volume":"27","author":"Bedecs","year":"1995","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.psc.2009.05.004_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","article-title":"The oxytocin receptor system: structure, function, and regulation","volume":"81","author":"Gimpl","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.psc.2009.05.004_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0079-6123(08)00436-6","article-title":"Impact of prosocial neuropeptides on human brain function","volume":"170","author":"Meyer-Lindenberg","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.psc.2009.05.004_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2006.12.009","article-title":"Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice","volume":"178","author":"Egashira","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.psc.2009.05.004_bib20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1017\/S003329170800384X","article-title":"A developmental twin study of symptoms of anxiety and depression: evidence for genetic innovation and attenuation","volume":"38","author":"Kendler","year":"2008","journal-title":"Psychol Med"},{"key":"10.1016\/j.psc.2009.05.004_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/da.20539","article-title":"Phenotypic and genetic differentiation of anxiety-related behaviors in middle childhood","volume":"26","author":"Hallett","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.psc.2009.05.004_bib22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpsychires.2005.08.012","article-title":"Decreased blood flow of temporal regions of the brain in subjects with panic disorder","volume":"40","author":"Lee","year":"2006","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.psc.2009.05.004_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00702-008-0077-9","article-title":"Neuroimaging in anxiety disorders","volume":"116","author":"Engel","year":"2009","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.psc.2009.05.004_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/15622970701216673","article-title":"fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder","volume":"8","author":"Pfleiderer","year":"2007","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001756-200303030-00006","article-title":"Brain regions showing increased activation by threat-related words in panic disorder","volume":"14","author":"Maddock","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.psc.2009.05.004_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archpsyc.62.8.922","article-title":"Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis","volume":"62","author":"van den Heuvel","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib27","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1097\/00001756-200112210-00020","article-title":"Functional MRI changes during panic anticipation and imagery exposure","volume":"12","author":"Bystritsky","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.psc.2009.05.004_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jad.2006.04.007","article-title":"fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection","volume":"94","author":"Pillay","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1016\/j.psc.2009.05.004_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","article-title":"Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study","volume":"55","author":"Malizia","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/appi.ajp.157.7.1120","article-title":"Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder","volume":"157","author":"Bremner","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(99)00188-2","article-title":"SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder","volume":"47","author":"Bremner","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-3956(95)00019-2","article-title":"Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT","volume":"29","author":"Kaschka","year":"1995","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.psc.2009.05.004_bib33","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1176\/appi.ajp.161.12.2186","article-title":"Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder","volume":"161","author":"Goddard","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pnpbp.2006.10.011","article-title":"Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study","volume":"31","author":"Ham","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0006-3223(02)01672-4","article-title":"Molecular targets in the treatment of anxiety","volume":"52","author":"Kent","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)37253-2","article-title":"Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors","volume":"284","author":"Helton","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.psc.2009.05.004_bib37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1017\/S1092852900010427","article-title":"The role of glutamate in anxiety and related disorders","volume":"10","author":"Cortese","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.psc.2009.05.004_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2147\/NDT.S1224","article-title":"Pharmacotherapy of panic disorder","volume":"4","author":"Pull","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.psc.2009.05.004_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00213-004-1950-3","article-title":"Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter","volume":"174","author":"Neumeister","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psc.2009.05.004_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jad.2007.05.006","article-title":"Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder","volume":"105","author":"Unschuld","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.psc.2009.05.004_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/da.20220","article-title":"HPA axis activity in patients with panic disorder: review and synthesis of four studies","volume":"24","author":"Abelson","year":"2007","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.psc.2009.05.004_bib43","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.158.10.1568","article-title":"A review and meta-analysis of the genetic epidemiology of anxiety disorders","volume":"158","author":"Hettema","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archpsyc.62.2.182","article-title":"The structure of genetic and environmental risk factors for anxiety disorders in men and women","volume":"62","author":"Hettema","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.c.30174","article-title":"The genetic basis of panic and phobic anxiety disorders","volume":"148","author":"Smoller","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.psc.2009.05.004_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11920-001-0010-5","article-title":"The genetics of panic disorder","volume":"3","author":"Finn","year":"2001","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.psc.2009.05.004_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.biopsych.2006.04.018","article-title":"A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci","volume":"60","author":"Fyer","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib48","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.psc.2009.05.004_bib49","article-title":"Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR)","author":"Strug","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib50","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ajmg.b.30750","article-title":"Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case\/control study for panic disorder","volume":"147B","author":"Keck","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.psc.2009.05.004_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ajmg.b.30773","article-title":"Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder","volume":"150B","author":"Hodges","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.psc.2009.05.004_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0033291707002231","article-title":"Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder","volume":"38","author":"Bryant","year":"2008","journal-title":"Psychol Med"},{"key":"10.1016\/j.psc.2009.05.004_bib53","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.neuropsychologia.2008.01.007","article-title":"An fMRI investigation of memory encoding in PTSD: influence of symptom severity","volume":"46","author":"Dickie","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.psc.2009.05.004_bib54","first-page":"142","article-title":"Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder","volume":"33","author":"Bryant","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.psc.2009.05.004_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pscychresns.2007.07.007","article-title":"Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq war veterans","volume":"162","author":"Morey","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psc.2009.05.004_bib56","first-page":"413","article-title":"The neural networks of inhibitory control in posttraumatic stress disorder","volume":"33","author":"Falconer","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.psc.2009.05.004_bib57","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/da.20292","article-title":"Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder","volume":"25","author":"Strawn","year":"2008","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.psc.2009.05.004_bib58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2826.2008.01701.x","article-title":"Biology of post-traumatic stress disorder in childhood and adolescence","volume":"20","author":"Pervanidou","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.psc.2009.05.004_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-007-1002-x","article-title":"Noradrenergic-glucocorticoid mechanisms in emotion-induced amnesia: from adaptation to disease","volume":"197","author":"Hurlemann","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psc.2009.05.004_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00004714-199802000-00003","article-title":"An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder","volume":"18","author":"Marshall","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2009.05.004_bib61","series-title":"Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine. Treatment of posttraumatic stress disorder: an assessment of the evidence","year":"2008"},{"key":"10.1016\/j.psc.2009.05.004_bib62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biopsych.2005.08.027","article-title":"Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping","volume":"59","author":"Yehuda","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"17","key":"10.1016\/j.psc.2009.05.004_bib63","first-page":"41","article-title":"Biology of posttraumatic stress disorder","volume":"62","author":"Yehuda","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib64","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0006-3223(91)90123-4","article-title":"Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder","volume":"30","author":"Yehuda","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpsychires.2005.08.002","article-title":"Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review","volume":"40","author":"de Kloet","year":"2006","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.psc.2009.05.004_bib66","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yhbeh.2006.06.019","article-title":"Role of corticotropin releasing factor in anxiety disorders: a translational research perspective","volume":"50","author":"Risbrough","year":"2006","journal-title":"Horm Behav"},{"key":"10.1016\/j.psc.2009.05.004_bib67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0006-3223(95)00197-2","article-title":"Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects","volume":"39","author":"Fossey","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2009.05.004_bib68","first-page":"22","article-title":"Neurobiological mechanisms in generalized anxiety disorder","volume":"62","author":"Nutt","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-199006000-00004","article-title":"Low urinary cortisol excretion in patients with posttraumatic stress disorder","volume":"178","author":"Yehuda","year":"1990","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.psc.2009.05.004_bib70","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.psyneuen.2006.09.003","article-title":"HPA- and HPT-axis alterations in chronic posttraumatic stress disorder","volume":"31","author":"Olff","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psc.2009.05.004_bib71","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-3223(01)01264-1","article-title":"Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder","volume":"50","author":"Rasmusson","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib72","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/01.chi.0000084832.67701.0d","article-title":"Salivary cortisol responses to dexamethasone in adolescents with posttraumatic stress disorder","volume":"42","author":"Lipschitz","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000049028","article-title":"Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder","volume":"9","author":"Baker","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.psc.2009.05.004_bib74","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1176\/ajp.154.5.624","article-title":"Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder","volume":"154","author":"Bremner","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-3223(89)90050-4","article-title":"The corticotropin-releasing hormone test in patients with posttraumatic stress disorder","volume":"26","author":"Smith","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib76","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0006-3223(02)01357-4","article-title":"The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder","volume":"52","author":"Yehuda","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib77","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1176\/ajp.144.8.1068","article-title":"The DST and posttraumatic stress disorder","volume":"144","author":"Kudler","year":"1987","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib78","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","article-title":"When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders","volume":"160","author":"Raison","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib79","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S1092852900008889","article-title":"Genetics of posttraumatic stress disorder","volume":"8","author":"Segman","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.psc.2009.05.004_bib80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3956(01)00032-2","article-title":"Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring","volume":"35","author":"Yehuda","year":"2001","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.psc.2009.05.004_bib81","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1017\/S0954579401003170","article-title":"Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion","volume":"13","author":"Yehuda","year":"2001","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.psc.2009.05.004_bib82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1375\/136905203765693870","article-title":"A high risk twin study of combat-related PTSD comorbidity","volume":"6","author":"Koenen","year":"2003","journal-title":"Twin Res"},{"key":"10.1016\/j.psc.2009.05.004_bib83","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1176\/appi.ajp.159.10.1675","article-title":"Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study","volume":"159","author":"Stein","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib84","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic variation of human serotonin transporter gene expression","volume":"66","author":"Heils","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.psc.2009.05.004_bib85","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.psc.2009.05.004_bib86","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.mp.4001546","article-title":"Gene-environment interaction analysis of serotonin system markers with adolescent depression","volume":"9","author":"Eley","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib87","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.mp.4001555","article-title":"Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden","volume":"10","author":"Grabe","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib88","doi-asserted-by":"crossref","first-page":"17316","DOI":"10.1073\/pnas.0404376101","article-title":"Social supports and serotonin transporter gene moderate depression in maltreated children","volume":"101","author":"Kaufman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.psc.2009.05.004_bib89","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.62.5.529","article-title":"The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication","volume":"62","author":"Kendler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0033291704002727","article-title":"The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression","volume":"35","author":"Gillespie","year":"2005","journal-title":"Psychol Med"},{"key":"10.1016\/j.psc.2009.05.004_bib91","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.biopsych.2005.10.026","article-title":"Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children","volume":"59","author":"Kaufman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib92","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1176\/appi.ajp.2007.06122007","article-title":"The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults","volume":"164","author":"Kilpatrick","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6123(08)62132-9","article-title":"Long-term behavioral and neuroendocrine adaptations to adverse early experience","volume":"122","author":"Ladd","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.psc.2009.05.004_bib94","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/sj.npp.1300769","article-title":"Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring","volume":"30","author":"Plotsky","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2009.05.004_bib95","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2007.26","article-title":"Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene","volume":"65","author":"Bradley","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib96","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.299.11.1291","article-title":"Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults","volume":"299","author":"Binder","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.psc.2009.05.004_bib97","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1074\/jbc.C100531200","article-title":"A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins","volume":"277","author":"Davies","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.psc.2009.05.004_bib98","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1210\/en.141.11.4107","article-title":"Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding","volume":"141","author":"Denny","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.psc.2009.05.004_bib99","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1074\/jbc.M407498200","article-title":"FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells","volume":"280","author":"Wochnik","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.psc.2009.05.004_bib100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.psc.2009.05.004_bib101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-3223(03)00692-9","article-title":"Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse","volume":"55","author":"Newport","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib102","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1176\/appi.ajp.161.8.1397","article-title":"The ACTH response to dexamethasone in PTSD","volume":"161","author":"Yehuda","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib103","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.mp.4001636","article-title":"Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors","volume":"10","author":"Segman","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib104","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.mp.4001727","article-title":"Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children","volume":"10","author":"Koenen","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1037\/0033-2909.129.1.52","article-title":"Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis","volume":"129","author":"Ozer","year":"2003","journal-title":"Psychol Bull"},{"key":"10.1016\/j.psc.2009.05.004_bib106","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.npp.1301205","article-title":"The neural correlates of social anxiety disorder and response to pharmacotherapy","volume":"31","author":"Kilts","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2009.05.004_bib107","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(08)60488-2","article-title":"Social anxiety disorder","volume":"371","author":"Stein","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2009.05.004_bib108","article-title":"Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants","author":"Hood","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.psc.2009.05.004_bib109","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0306-4530(01)00070-1","article-title":"HPA axis response to a psychological stressor in generalised social phobia","volume":"27","author":"Condren","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psc.2009.05.004_bib110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.biopsych.2008.08.022","article-title":"Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behavior in social phobia","volume":"65","author":"Roelofs","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib111","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.psyneuen.2008.07.004","article-title":"Elevated alpha-amylase but not cortisol in generalized social anxiety disorder","volume":"33","author":"van Veen","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psc.2009.05.004_bib112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1520-6394(1999)10:1<25::AID-DA4>3.0.CO;2-O","article-title":"Salivary cortisol levels in socially phobic adolescent girls","volume":"10","author":"Martel","year":"1999","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.psc.2009.05.004_bib113","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0006-3223(01)01375-0","article-title":"Superior temporal gyrus volumes in pediatric generalized anxiety disorder","volume":"51","author":"De Bellis","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib114","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1176\/appi.ajp.163.6.1091","article-title":"Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder","volume":"163","author":"Monk","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.161.6.1119","article-title":"Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study","volume":"161","author":"Mathew","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib116","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nature07166","article-title":"Switching on and off fear by distinct neuronal circuits","volume":"454","author":"Herry","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.psc.2009.05.004_bib117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pbb.2008.02.023","article-title":"Changes in amygdala neural activity that occur with the extinction of context-dependent conditioned fear stress","volume":"90","author":"Izumi","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.psc.2009.05.004_bib118","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1749-6632.2003.tb07084.x","article-title":"Role of the amygdala in fear extinction measured with potentiated startle","volume":"985","author":"Davis","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.psc.2009.05.004_bib119","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1749-6632.2003.tb07095.x","article-title":"Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala","volume":"985","author":"Anand","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.psc.2009.05.004_bib120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1749-6632.2003.tb07096.x","article-title":"Neuroimaging studies of amygdala function in anxiety disorders","volume":"985","author":"Rauch","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.psc.2009.05.004_bib121","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.65.5.568","article-title":"Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder","volume":"65","author":"Monk","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib122","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-006-0542-9","article-title":"fMRI predictors of treatment outcome in pediatric anxiety disorders","volume":"191","author":"McClure","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psc.2009.05.004_bib123","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.biopsych.2007.08.019","article-title":"A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder","volume":"63","author":"Whalen","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib124","first-page":"133","article-title":"The role of GABA in the pathophysiology and treatment of anxiety disorders","volume":"37","author":"Nemeroff","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.psc.2009.05.004_bib125","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1176\/appi.ajp.162.12.2379","article-title":"Open-label trial of riluzole in generalized anxiety disorder","volume":"162","author":"Mathew","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib126","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00023210-200822090-00004","article-title":"Riluzole in the treatment of mood and anxiety disorders","volume":"22","author":"Pittenger","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psc.2009.05.004_bib127","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00406-004-0520-3","article-title":"SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder","volume":"254","author":"Maron","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2009.05.004_bib128","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0006-3223(98)00272-8","article-title":"Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography","volume":"44","author":"Malison","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(03)00110-1","article-title":"Sensitivity to cholecystokinin-tetrapeptide in major depression","volume":"80","author":"Koszycki","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.psc.2009.05.004_bib130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/ajp.154.5.700","article-title":"Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder","volume":"154","author":"Brawman-Mintzer","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib131","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0006-3223(99)00090-6","article-title":"Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder","volume":"46","author":"Pande","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2009.05.004_bib132","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psc.2009.05.004_bib133","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.npep.2004.05.006","article-title":"Interactions between NPY and CRF in the amygdala to regulate emotionality","volume":"38","author":"Sajdyk","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psc.2009.05.004_bib134","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.103.058784","volume":"309","author":"Lelas","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.psc.2009.05.004_bib135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0893-133X(01)00244-5","article-title":"Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent","volume":"25","author":"Millan","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2009.05.004_bib136","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","article-title":"Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450","volume":"485","author":"Chaki","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.psc.2009.05.004_bib137","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","article-title":"Central CRH system in depression and anxiety\u2014evidence from clinical studies with CRH1 receptor antagonists","volume":"583","author":"Holsboer","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.psc.2009.05.004_bib138","first-page":"S367","article-title":"Recent perspectives on the diagnosis and treatment of generalized anxiety disorder","volume":"7","author":"Ninan","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.psc.2009.05.004_bib139","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005053-200107000-00001","article-title":"A population-based twin study of generalized anxiety disorder in men and women","volume":"189","author":"Hettema","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.psc.2009.05.004_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.10013","article-title":"Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression","volume":"117B","author":"Tadic","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.psc.2009.05.004_bib141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00041444-200503000-00002","article-title":"Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder","volume":"15","author":"You","year":"2005","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.psc.2009.05.004_bib142","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/da.20528","article-title":"RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults","volume":"26","author":"Koenen","year":"2009","journal-title":"Depress Anxiety"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X09000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X09000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:34:20Z","timestamp":1739295260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X09000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":142,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0193953X09000501"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2009.05.004","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}